Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178412 · ClinicalTrials.gov registry record · Phase 2
Improving Outcomes of Hospitalized Elders and Caregivers
A Phase 2 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 2
- Development phase
- 421
- Enrollment target
NCT00178412: Completed Phase 2 study, sponsored by University of Rochester.
NCT00178412 is a Phase 2 study that has completed, run by University of Rochester. The registered enrollment target is 421 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (217% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00178412, a Phase 2 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 421 participants
- Enrollment target
Study Summary
In this study, an intervention is tested that is designed to improve the outcomes of hospitalized elders and family caregivers. Study design: * randomized, controlled study * participants: 280 family caregivers aged 21 or above * length of follow-up: 2 weeks and 2 months after hospitalization Study hypothesis: In this randomized clinical trial, the following hypotheses will be tested: 1. Hospitalized elders whose family CGs receive the CARE program versus those who receive a comparison program will have better outcomes during and after hospitalization as measured by: (1) fewer incidents of dysfunctional syndrome; (2) shorter hospital stays; (3) lower readmission rates; (4) less depressive symptoms; (5) higher cognitive level; (6) less functional decline perceived by family CG; and (7) a closer relationship with their family CGs. 2. Family CGs of hospitalized elders who receive the CARE program will report: (1) More positive beliefs about their loved one's responses to hospitalization and their role in the hospital setting; (2) more positive emotional outcomes (less worry, anxiety, and depressive symptoms) during and after hospitalization; (3) More participation in their loved one's care during hospitalization; and (4) More positive role outcomes (more role reward, less role strain, more prepared for their loved one's care, and a closer relationship with their elderly relatives, both during and after hospitalization). 3. The proposed model to explain the effects of the CARE program on the process and outcomes of family CG coping and elderly patient outcomes will be supported for CGs and elderly patients.
Interventions
- BEHAVIORAL Comparison Group
- BEHAVIORAL Care Project for Hospitalized Elders & Family Caregivers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 421 participants |
| Start Date | 2003-04 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
What the finished NCT00178412 record still lists
NCT00178412 is an interventional study that assigns participants to a tested intervention. The registered 421 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (217% higher).
The record links to 0 conditions, and to 2 interventions - of which Comparison Group is the first listed.
NCT00178412 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00178412 about?
NCT00178412 is a clinical study titled "Improving Outcomes of Hospitalized Elders and Caregivers". In this study, an intervention is tested that is designed to improve the outcomes of hospitalized elders and family caregivers. Study design: * randomized, controlled study * participants: 280 family caregivers aged 21 or above * length of follow-up: 2 weeks and 2 months after hospitalization Stu...
What is the current status of trial NCT00178412?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 421 participants. The study started on 2003-04. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00178412?
The interventions under investigation include: Comparison Group (BEHAVIORAL), Care Project for Hospitalized Elders & Family Caregivers (BEHAVIORAL).
Who is sponsoring clinical trial NCT00178412?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00178412's enrollment target sits among peer trials
421 91st of 2000 higher than 1,910 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05976763 · 421 participants · Phase 3
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
- NCT07114601 · 421 participants · Phase 1
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- NCT04763356 · 422 participants · NA
Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy
- NCT06837246 · 422 participants · NA
A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia